$ cat ./records/gates-foundation-backs-14-million-person-yellow-fever-campaign-in-2016.txt
Gates Foundation Backs 14-Million-Person Yellow Fever Campaign in Angola and DRC
[RECORD.TXT] · cat --full
The Gates Foundation supported a rapid yellow fever vaccination campaign in Angola and the Democratic Republic of Congo — the largest yellow fever emergency response in history — after an outbreak spread to 11 provinces and crossed into DRC. Over 10 days, 41,000 health workers vaccinated 14 million people using fractional-dose vaccine strategy at one-fifth the normal dose, which the WHO validated as protective. The campaign halted the outbreak and proved fractional dosing as a viable emergency strategy for future stockpile shortfalls.
Source: https://www.gatesfoundation.org/ideas/articles/world-immunization-week-africa
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Launches Breakthrough Energy Ventures with $1 Billion Climate Fund
Next →
Gates Foundation Awards $38 Million Polio Vaccine Grant to Takeda
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.